|
| Exchange Received Time 04/08/2018 14:44:42 Exchange Disseminated Time 04/08/2018 14:44:51 Time Taken 00:00:09 | ASPIRA PATHLAB has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2018 ,inter alias, to consider and approve We wish to inform you that, pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, August 11, 2018 to consider and approve, inter alia, the unaudited financial results of the Company for the quarter ended June 30,2018.
Pursuant to Company's Internal Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company will remain closed from Monday August 06, 2018 and shall open 48 hours after announcement of the outcome of the said meeting, for all its designated persons.
|
|
|